Portfolio company
CVRx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ceryx Medical
This company develops bioelectronic medical devices and pacing technology to treat patients with heart failure, hypertension and neurological injuries.
NeuroTronik
This medical technology company develops neurostimulation systems for clinicians to treat patients suffering from acute heart failure.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
Levron
This company develops a cardio-respiratory physiological assist device that synchronises heart rhythm with respiratory dynamics for patients with chronic heart failure.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
V-Wave
This company develops implantable interatrial shunts to regulate heart pressure and reduce hospitalisations for patients suffering from chronic heart failure.
Cardiac Dimensions
This company develops minimally invasive heart implants to treat functional mitral regurgitation in patients with heart failure.
iRiva Medical
This company develops implantable neuromodulation technology platforms to treat patients suffering from chronic diseases.
